Showing results (251-260 of 408) with videos related to
Sort By:
Pageof 41
Cell|April 2, 2013
Somatic mutations of the immunoglobulin framework are generally required for broad and potent HIV-1 neutralizationFlorian Klein, Ron Diskin, Johannes F Scheid, et al.Plos Pathogens|October 31, 2015
A New Glycan-Dependent CD4-Binding Site Neutralizing Antibody Exerts Pressure on HIV-1 In VivoNatalia T Freund, Joshua A Horwitz, Lilian Nogueira, et al.Science (New York, N.Y.)|June 25, 2021
Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variantsYongfei Cai, Jun Zhang, Tianshu Xiao, et al.Proceedings of the National Academy of Sciences of the United States of America|November 23, 2016
Paired quantitative and qualitative assessment of the replication-competent HIV-1 reservoir and comparison with integrated proviral DNAJulio C C Lorenzi, Yehuda Z Cohen, Lillian B Cohn, et al.The Journal of Biological Chemistry|August 28, 2014
A fusion intermediate gp41 immunogen elicits neutralizing antibodies to HIV-1Rachel P J Lai, Miriam Hock, Jens Radzimanowski, et al.The Journal of Infectious Diseases|March 14, 2013
Safety and immunogenicity of modified vaccinia Ankara in hematopoietic stem cell transplant recipients: a randomized, controlled trialStephen R Walsh, Marissa B Wilck, David J Dominguez, et al.Journal of Virology|May 26, 2017
Virological Control by the CD4-Binding Site Antibody N6 in Simian-Human Immunodeficiency Virus-Infected Rhesus MonkeysBoris Julg, Amarendra Pegu, Peter Abbink, et al.Biorxiv : the Preprint Server for Biology|April 21, 2021
Structural basis for enhanced infectivity and immune evasion of SARS-CoV-2 variantsYongfei Cai, Jun Zhang, Tianshu Xiao, et al.Proceedings of the National Academy of Sciences of the United States of America|March 24, 2023
Indoline CD4-mimetic compounds mediate potent and broad HIV-1 inhibition and sensitization to antibody-dependent cellular cytotoxicityChristopher J Fritschi, Saumya Anang, Zhen Gong, et al.Open Forum Infectious Diseases|August 14, 2023
Delayed and Attenuated Antibody Responses to Coronavirus Disease 2019 Vaccination With Poor Cross-Variant Neutralization in Solid-Organ Transplant Recipients-A Prospective Longitudinal StudyMay Y Liew, Josh I Mathews, Amy Li, et al.Pageof 41